Coverage of Bullish (BLSH) is relatively fresh, since the stock listed in August 2025, and targets have been revised frequently as crypto markets and the company's strategy have shifted. The most current, attributable targets I reviewed include J.P. Morgan at $28 (Hold), Keefe Bruyette at $40 (Market Perform, trimmed from $55 by analyst Stephen Glagola in late September 2026), Canaccord Genuity at $45 (Buy), and Citi at $50 (Buy, from analyst Peter Christiansen in October 2026). The average of these four recent figures is about $41, which I round to a clean central target of $40.
The full range is unusually wide. Independent trackers report the low end near $25 and the high end from roughly $52 to $65, with average consensus figures landing anywhere from about $39 to $48 depending on which older targets are included. The dispersion reflects a genuine split: bullish analysts emphasize the exchange's liquidity engine and media reach, while cautious analysts cite weak profitability and the difficulty of justifying the Equiniti purchase price. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Bullish (BLSH) traded near $20.36 in mid-November 2026, with a market capitalization of roughly $3.1 billion and a 52-week range of about $18.80 to $48.93. Reaching the $40 central target therefore implies upside of approximately 96%, which qualifies as a very large move rather than a modest one. Notably, the shares have already traded above $40 in the past year, so the target is not unprecedented but would still require a substantial re-rating from current levels.
The path would likely depend on a combination of sustained trading volume on Bullish Exchange, progress monetizing the Equiniti transfer-agent business, and renewed investor appetite for crypto-linked equities. The company's most recent quarterly report showed a positive EPS surprise, but the business has also posted large GAAP losses in prior quarters.
Bullish (BLSH) operates a regulated, institutional-grade spot and derivatives exchange that pairs a central limit order book with automated market making, a model designed to deliver deep liquidity. Its ownership of CoinDesk adds recurring media, data, and index revenue that could diversify the business away from pure transaction fees. The agreed acquisition of Equiniti, announced in May 2026 for roughly $4.2 billion, would add a transfer-agent platform serving thousands of issuers, potentially broadening revenue and cross-selling tokenized-equity services. A favorable regulatory backdrop under Europe's MiCAR framework and any sustained rally in digital asset prices would likely support the stock.
The company's financial profile remains the central obstacle. Bullish (BLSH) has reported large net losses in recent quarters, and analysts such as Keefe Bruyette have questioned whether the Equiniti purchase price can be justified given limited tokenized-equity monetization and an uncertain market structure. Competition from established exchanges and brokers, regulatory risk across jurisdictions, and the stock's high volatility all weigh on the multiple. If digital asset volumes weaken or integration of Equiniti disappoints, the shares could struggle to hold even their current levels, let alone approach $40.
The 52-week low near $18.80 is a key support level to watch, sitting just below the current price. On the upside, round-number levels around $25 and $30 may act as psychological resistance, with the 52-week high near $48.93 marking the most durable zone before any test of $50 or beyond. The stock's steep decline from its 2025 highs means the $40 target sits well below prior peaks but still more than 90% above the recent low, leaving plenty of room for volatility in either direction.
Analyst price targets generally reflect a research horizon of roughly 12 months, though individual analysts apply different assumptions and timeframes. Investors tracking this question should monitor quarterly earnings and guidance, trading volume trends on Bullish Exchange, and analyst target revisions, which have been frequent. The completion and financing of the Equiniti acquisition, updates on tokenized-equity adoption, and broader crypto market conditions will all be critical. Macroeconomic and rate decisions that influence risk appetite should also be watched closely. From what I see, monitoring these factors closely helps clarify whether the path to $40 remains realistic.
The $40 central target reflects the average of several recent analyst price targets rather than a formal, widely published consensus, and the underlying range of roughly $25 to $52 underscores how divided the Street is on Bullish (BLSH). Reaching the target would require a gain of about 96% from the current price near $20.36, a very large move supported by the exchange franchise, CoinDesk assets, and the Equiniti deal, but offset by persistent losses, integration risk, and an uncertain competitive landscape. Whether the shares reach $40 depends on execution, crypto market momentum, and whether analysts keep revising targets higher rather than lower.
I regularly use Tickeron’s AI Daily Buy/Sell Signals as part of my routine review process. The tool applies AI to scan thousands of stocks and ETFs, delivering Buy, Sell, or Hold signals based on technical shifts and market conditions. It helps me spot potential changes in trend without replacing deeper fundamental work. For anyone following Bullish (BLSH) or similar names, it offers an efficient way to layer data-driven insights into ongoing research.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where BLSH declined for three days, in 74 of 81 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for BLSH turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 9 similar instances when the indicator turned negative. In 8 of the 9 cases the stock turned lower in the days that followed. This puts the odds of success at 89%.
The Aroon Indicator for BLSH entered a downward trend on November 17, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +10.09% 3-day Advance, the price is estimated to grow further. Considering data from situations where BLSH advanced for three days, in 44 of 55 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
BLSH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 29 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.338) is normal, around the industry mean (16.188). P/E Ratio (-2.131) is within average values for comparable stocks, (45.064). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.427) among similar stocks. P/S Ratio (0.026) is also within normal values, averaging (103.301).
The Tickeron PE Growth Rating for this company is 38 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 84 (best 1 - 100 worst), indicating slightly worse than average price growth. BLSH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BLSH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry ComputerCommunications